Revenue, Profit Growth Prospects Look Good For Financial Big Cap Leaders

As IBD stock screens go, the IBD Big Cap 20 is of a different stripe. A primary focus on large-capitalization stocks distinguishes it from the high-growth slant of the IBD 50 or Your Weekly Review. But that doesn’t mean that the IBD Big Cap 20, which runs in Tuesday’s paper, won’t find its fair share of winning stocks before they start big price advances.

Key Takeaways:

• While the Trump presidential victory unleashed a torrent of dollars into commodity and cyclical companies (think banking, building materials, and heavy construction).
• the IBD 50 is carrying another important message: Don’t forget about technology.
• Semiconductor, optical and wireless firms made up no fewer than seven of the top 25 places within the IBD 50 as of Thursday’s market close.

“IBD’s investing strategy, products and content help you make more money in the stock market.”

http://www.investors.com/stock-lists/ibd-big-cap-20/revenue-profit-growth-prospects-look-good-for-financial-big-cap-leaders/